Company intelligence / Profile preview
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai, Chinasphchina.com ↗
- Ownership
- Private
- Employees
- ~48164
- Development stage
- Other
01
Overview
Shanghai Pharmaceuticals has 118 drug pipelines with 38 approved drugs. The company focuses on various therapeutic areas including neoplasms (33 drugs), skin and musculoskeletal diseases (23 drugs), nervous system diseases (22 drugs), and cardiovascular diseases (22 drugs).
- Therapeutic areas
- GastroenterologyCardiovascularImmunologyDermatologyHematologyOncologyNeurologyInfectious Diseases
- Modalities
- Chemical drugsTraditional Chinese medicines
- Industry
- Biotech
02
Drug pipeline
33 assets32 more assets in the full pipeline.
03
Partnerships
Acquired Cardinal Health's China operations in 2017
Beyond the preview
Go deeper on Shanghai Pharmaceuticals Holding Co Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Pharmaceuticals Holding Co Ltd.